MetaADEDB 2.0 @ LMMD
asfotase alfa
(LPAUOXUZGSBGDU-ULCCENQXSA-N)
Structure
SMILES
CCCN=C1S/C(=C\c2ccc(c(c2)Cl)OC[C@@H](CO)O)/C(=O)N1c1ccccc1C
Type(s)
Investigational
Molecular Formula:
C23H25ClN2O4S
Molecular Weight:
460.974
Log P:
4.3323
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
107.66
CAS Number(s):
854107-55-4
Synonym(s)
1.
asfotase alfa
2.
ENB-0040
3.
Strensiq
External Link(s)
MeSHC570710
PubChem Compound11363176
BindingDB50316768
CHEMBLCHEMBL1096146
DrugBankDB12016
IUPHAR/BPS Guide to PHARMACOLOGY9320
KEGGdr:D11215
ZINC34509627
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood alkaline phosphatase increasedFAERS: 3US FAERS
2Respiratory FailureFAERS: 3US FAERS
3CraniosynostosisFAERS: 2US FAERS
4Injection site erythemaFAERS: 2US FAERS
5Irregular breathingFAERS: 2US FAERS
6PneumoniaFAERS: 2US FAERS
7SepsisFAERS: 2US FAERS
8WheezingFAERS: 2US FAERS
9AstheniaFAERS: 1US FAERS
10Blood phosphorus increasedFAERS: 1US FAERS
11Blood potassium decreasedFAERS: 1US FAERS
12Chest PainFAERS: 1US FAERS
13Chest discomfortFAERS: 1US FAERS
14DehydrationFAERS: 1US FAERS
15Electrolyte imbalanceFAERS: 1US FAERS
16Growth retardationFAERS: 1US FAERS
17Injection Site ReactionFAERS: 1US FAERS
18Injection site massFAERS: 1US FAERS
19NauseaFAERS: 1US FAERS
20OsteopeniaFAERS: 1US FAERS
21PlatyspondyliaFAERS: 1US FAERS
22Rachitic rosaryFAERS: 1US FAERS
23Respiratory distressFAERS: 1US FAERS
24SnoringFAERS: 1US FAERS
25Status EpilepticusFAERS: 1US FAERS
26Tooth LossFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.